8 Einträge gefunden

1. Sex differences among patients receiving ticagrelor monotherapy or aspirin after coronary bypass surgery: A prespecified subgroup analysis of the TiCAB trial

   1. Sandner, Sigrid
   2. Kastrati, Adnan
   3. Niessner, Alexander
   4. Böning, Andreas
   5. Zeymer, Uwe
   6. Conradi, Lenard
   7. Danner, Bernhard

   2023 - Forschungsinformationssystem des UKE
2. Patients selected for dual pathway inhibition in clinical practice have similar characteristics and outcomes to those included in the COMPASS randomized trial:The XATOA Registry

   1. Fox, Keith A A
   2. Aboyans, Victor
   3. Debus, E Sebastian
   4. Zeymer, Uwe
   5. Cowie, Martin R
   6. Patel, Manesh
   7. Welsh, Robert C

   2022 - Forschungsinformationssystem des UKE
3. Impact of atrial fibrillation pattern on outcomes after left atrial appendage closure: lessons from the prospective LAARGE registry

   1. Kany, Shinwan
   2. Brachmann, Johannes
   3. Lewalter, Thorsten
   4. Akin, Ibrahim
   5. Sievert, Horst
   6. Zeymer, Uwe
   7. Ledwoch, Jakob

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Influence of severe anemia on procedural safety and one-year outcome after left atrial appendage closure: Insights from a very high-risk cohort

   1. Kany, Shinwan
   2. Brachmann, Johannes
   3. Lewalter, Thorsten
   4. Akin, Ibrahim
   5. Sievert, Horst
   6. Zeymer, Uwe
   7. Hochadel, Matthias

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
5. Impact of Center Volume on Outcomes in Myocardial Infarction Complicated by Cardiogenic Shock: A CULPRIT-SHOCK Substudy

   1. Schrage, Benedikt
   2. Zeymer, Uwe
   3. Montalescot, Gilles
   4. Windecker, Stephan
   5. Serpytis, Pranas
   6. Vrints, Christiaan
   7. Stepinska, Janina

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
6. Importance of swift event adjudication of endpoints for adequate reporting to data and safety monitoring boards in clinical trials-lessons from CULPRIT-SHOCK

   1. Clemmensen, Peter
   2. Schrage, Benedikt
   3. Zeymer, Uwe
   4. Thiele, Holger
   5. Wegscheider, Karl

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
7. Xarelto plus Acetylsalicylic acid: Treatment patterns and Outcomes in patients with Atherosclerosis (XATOA): Rationale and design of a prospective registry study to assess rivaroxaban 2.5 mg twice daily plus aspirin for prevention of atherothrombotic events in coronary artery disease, peripheral artery disease, or both

   1. Fox, Keith A A
   2. Anand, Sonia S
   3. Aboyans, Victor
   4. Cowie, Martin R
   5. Debus, E Sebastian
   6. Zeymer, Uwe
   7. Monje, Danja

   2020 - Forschungsinformationssystem des UKE
8. Dual Pathway Inhibition with Low-Dose Direct Factor Xa Inhibition after Acute Coronary Syndromes-Why Is It Not Used in Clinical Practice?

   1. Zeymer, Uwe
   2. Schrage, Benedikt
   3. Westermann, Dirk

   2018 - Forschungsinformationssystem des UKE